Free Trial

Fortrea (FTRE) Competitors

Fortrea logo
$8.36 -0.09 (-1.07%)
Closing price 04:00 PM Eastern
Extended Trading
$8.36 0.00 (0.00%)
As of 04:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FTRE vs. SHC, SGRY, BTSG, PRVA, CON, WGS, LFST, VCYT, ARDT, and PACS

Should you be buying Fortrea stock or one of its competitors? The main competitors of Fortrea include Sotera Health (SHC), Surgery Partners (SGRY), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), GeneDx (WGS), LifeStance Health Group (LFST), Veracyte (VCYT), Ardent Health Partners (ARDT), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

Fortrea vs.

Fortrea (NASDAQ:FTRE) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

Sotera Health has lower revenue, but higher earnings than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fortrea$2.70B0.28-$3.40M-$3.69-2.29
Sotera Health$1.10B3.01$51.38M$0.1577.93

91.0% of Sotera Health shares are owned by institutional investors. 0.1% of Fortrea shares are owned by company insiders. Comparatively, 55.1% of Sotera Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sotera Health received 40 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 58.62% of users gave Sotera Health an outperform vote while only 22.92% of users gave Fortrea an outperform vote.

CompanyUnderperformOutperform
FortreaOutperform Votes
11
22.92%
Underperform Votes
37
77.08%
Sotera HealthOutperform Votes
51
58.62%
Underperform Votes
36
41.38%

Sotera Health has a net margin of 6.31% compared to Fortrea's net margin of -10.99%. Sotera Health's return on equity of 42.27% beat Fortrea's return on equity.

Company Net Margins Return on Equity Return on Assets
Fortrea-10.99% 2.00% 0.80%
Sotera Health 6.31%42.27%6.02%

In the previous week, Fortrea had 7 more articles in the media than Sotera Health. MarketBeat recorded 11 mentions for Fortrea and 4 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.40 beat Fortrea's score of 0.18 indicating that Sotera Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fortrea
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
Sotera Health
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fortrea has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500. Comparatively, Sotera Health has a beta of 1.92, indicating that its share price is 92% more volatile than the S&P 500.

Fortrea currently has a consensus target price of $19.00, suggesting a potential upside of 124.85%. Sotera Health has a consensus target price of $16.00, suggesting a potential upside of 36.87%. Given Fortrea's higher possible upside, analysts clearly believe Fortrea is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fortrea
1 Sell rating(s)
11 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.92
Sotera Health
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

Summary

Sotera Health beats Fortrea on 15 of the 18 factors compared between the two stocks.

Remove Ads
Get Fortrea News Delivered to You Automatically

Sign up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FTRE vs. The Competition

MetricFortreaMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$762.19M$2.89B$5.62B$8.13B
Dividend YieldN/A21.70%4.56%4.00%
P/E Ratio-2.4713.2424.5219.09
Price / Sales0.28201.14385.6194.71
Price / Cash6.2857.5638.1634.64
Price / Book0.434.586.934.36
Net Income-$3.40M-$22.21M$3.20B$247.23M
7 Day Performance-3.65%-1.66%-2.20%-0.34%
1 Month Performance-39.86%-2.50%3.13%-3.60%
1 Year Performance-78.92%0.93%10.99%2.01%

Fortrea Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FTRE
Fortrea
2.5207 of 5 stars
$8.36
-1.1%
$19.00
+127.3%
-78.2%$754.07M$2.70B-2.4418,000
SHC
Sotera Health
2.8541 of 5 stars
$11.93
+2.9%
$15.92
+33.4%
+1.4%$3.38B$1.10B47.723,000Positive News
SGRY
Surgery Partners
2.4965 of 5 stars
$24.40
+3.4%
$36.63
+50.1%
-17.7%$3.11B$3.11B-50.8313,500Analyst Forecast
BTSG
BrightSpring Health Services
2.7106 of 5 stars
$17.45
+0.2%
$21.67
+24.2%
+87.3%$3.05B$11.27B-67.1235,000
PRVA
Privia Health Group
3.6272 of 5 stars
$23.24
-2.1%
$26.67
+14.7%
+20.6%$2.80B$1.74B232.421,102Positive News
CON
Concentra Group Holdings Parent
N/A$21.04
+1.2%
$28.38
+34.8%
N/A$2.68B$1.90B13.9411,000Positive News
WGS
GeneDx
2.3569 of 5 stars
$94.46
-4.1%
$72.33
-23.4%
+1,003.4%$2.65B$305.45M-48.191,200Positive News
LFST
LifeStance Health Group
2.4111 of 5 stars
$6.89
-0.4%
$8.63
+25.2%
+10.9%$2.65B$1.25B-26.509,325
VCYT
Veracyte
4.5682 of 5 stars
$31.23
-0.9%
$43.00
+37.7%
+46.7%$2.43B$445.76M-208.20790Analyst Forecast
News Coverage
ARDT
Ardent Health Partners
N/A$14.02
+0.9%
$21.18
+51.1%
N/A$2.00B$5.97B0.0024,200Analyst Forecast
News Coverage
Positive News
PACS
PACS Group
3.846 of 5 stars
$12.30
+4.1%
$34.00
+176.5%
N/A$1.87B$3.56B0.0032,433Options Volume
News Coverage
Remove Ads

Related Companies and Tools


This page (NASDAQ:FTRE) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners